Literature DB >> 17598510

Retrospective study of the prevalence of high-risk human papillomaviruses among Croatian women.

Nina Milutin-Gasperov1, Ivan Sabol, Gordana Halec, Mihaela Matovina, Magdalena Grce.   

Abstract

The infection with Human papillomavirus (HPV) is the necessary cause for cervical cancer. There are at least 15 High-Risk (HR) HPV types that are significantly associated with progression of cervical intraepithelial neoplasia to cervical cancer. Since previous studies showed that the prevalence of HPV in cervical cancers varies among different geographic regions, we wanted to investigate the prevalence of HPV types in Croatia, especially low abundant HR HPV types. By means of consensus primers directed polymerase chain reaction (PCR), we analysed cervical DNA samples of 2,136 Croatian women, mostly with abnormal cervical smears, in order to detect the presence of HPV Type-specific primers were then used to determine Low-Risk (LR) HPV types 6/11 and HR HPV types 16, 18, 31, 33, 45, 52 and 58. Out of 2,136 specimens, 1,255 (58.8%) were positive for HPV More than half of positive samples were typed (64.5%) and 35.5% still remained untyped. Multiple HPV infections were found in 10.3% of the cases. The most prevalent type, including both single and multiple infections, was HPV16 with the prevalence of 15.9%, followed by HPV types 31, 6/11, 33, 18, 52, 45 and 58 with 8.7%, 7.1%, 4.5%, 3.8%, 2.3%, 1.2% and 1.1%, respectively. The significant increase of frequency from Low-grade Squamous Intraepithelial Lesions (LSIL) to High-grade Squamous Intraepithelial Lesions (HSIL) was observed for HR HPV types 16, 18, 31 and 33 but not 45, 52 and 58. The frequency of unknown HPV types was almost the same in cervical specimens of women with LSIL and those with HSIL, 19.8% and 21.1%, respectively. The prevalence of HPV infection rate decreased significantly with patient age from 68.5% (age group 12 to 24 years) to 38.8% (age group 45 to 54 years). But, in women aged 55 or older the overall prevalence increased to 56.6%. Our results indicate that prevalence of HR HPV types in Croatia is similar to other countries. We suggest that HPV positive women in Croatia should be closely monitored by typing for HR HPV types: 16, 18, 31, 33, 45, 52 and 58.

Entities:  

Mesh:

Year:  2007        PMID: 17598510

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  12 in total

Review 1.  Worldwide impact of the human papillomavirus vaccine.

Authors:  Amy A Hakim; Tri A Dinh
Journal:  Curr Treat Options Oncol       Date:  2009-04-23

2.  Detection and typing of human papillomaviruses combining different methods: polymerase chain reaction, restriction fragment length polymorphism, line probe assay and sequencing.

Authors:  Nina Milutin Gasperov; Ivan Sabol; Mihaela Matovina; Sime Spaventi; Magdalena Grce
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

3.  Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears.

Authors:  I Salimović-Bešić; M Hukić
Journal:  Epidemiol Infect       Date:  2015-01-12       Impact factor: 4.434

4.  Changes in human immunodeficiency virus and sexually transmitted infections-related sexual risk taking among young Croatian adults: 2005 and 2010 population-based surveys.

Authors:  Ivan Landripet; Aleksandar Stulhofer; Valerio Bacak
Journal:  Croat Med J       Date:  2011-08-15       Impact factor: 1.351

5.  Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia.

Authors:  Ivan Sabol; Nina Milutin Gašperov; Mihaela Matovina; Ksenija Božinović; Goran Grubišić; Ivan Fistonić; Dragan Belci; Laia Alemany; Sonja Džebro; Mara Dominis; Mario Šekerija; Sara Tous; Silvia de Sanjosé; Magdalena Grce
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

6.  Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer.

Authors:  Ksenija Božinović; Ivan Sabol; Emil Dediol; Nina Milutin Gašperov; Spomenka Manojlović; Zuzana Vojtechova; Ruth Tachezy; Magdalena Grce
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

7.  Characterization and whole genome analysis of human papillomavirus type 16 e1-1374^63nt variants.

Authors:  Ivan Sabol; Mihaela Matovina; Ali Si-Mohamed; Magdalena Grce
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

8.  Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.

Authors:  Nina Milutin Gašperov; Ivan Sabol; Pavao Planinić; Goran Grubišić; Ivan Fistonić; Ante Ćorušić; Magdalena Grce
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

9.  Human papillomavirus in the lesions of the oral mucosa according to topography.

Authors:  Marinka Mravak-Stipetić; Ivan Sabol; Josip Kranjčić; Marjana Knežević; Magdalena Grce
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  DNA Methylome Distinguishes Head and Neck Cancer from Potentially Malignant Oral Lesions and Healthy Oral Mucosa.

Authors:  Nina Milutin Gašperov; Ivan Sabol; Ksenija Božinović; Emil Dediol; Marinka Mravak-Stipetić; Danilo Licastro; Simeone Dal Monego; Magdalena Grce
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.